TY  - GEN
AU  - Lofters,W S
AU  - Pater,J L
AU  - Zee,B
AU  - Dempsey,E
AU  - Walde,D
AU  - Moquin,J P
AU  - Wilson,K
AU  - Hoskins,P
AU  - Guevin,R M
AU  - Verma,S
AU  - Navari,R
AU  - Krook,J E
AU  - Hainsworth,J
AU  - Palmer,M
AU  - Chin,C
TI  - Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy
SN  - 0732-183X
PY  - 1997///0908
KW  - Administration, Oral
KW  - Antiemetics
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Dexamethasone
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Injections, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Nausea
KW  - chemically induced
KW  - Ondansetron
KW  - Premedication
KW  - Quality of Life
KW  - Quinolizines
KW  - Vomiting
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.1997.15.8.2966
ER  -